Differently from Peng et al. (2019) in the mechanism, Zhang Y. et al. (2020) revealed that circCPA4 sponges MEF2D (myocyte enhancer factor 2D)-targeting miR-760 to promote glioma progress. This evidence concerns the gene MEF2D and central nervous system cancer.